Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2014, Article ID 381985, 8 pages
http://dx.doi.org/10.1155/2014/381985
Clinical Study

Impaired Urine Dilution Capability in HIV Stable Patients

1Infectious Diseases Section, Internal Medicine Service, Hospital Italiano de Buenos Aires, Peron 4190, 1181 ACH Buenos Aires, Argentina
2Renal Physiology Section, Nephrology Service, Hospital Italiano de Buenos Aires, Peron 4190, 1181 ACH Buenos Aires, Argentina

Received 16 November 2013; Revised 2 February 2014; Accepted 17 February 2014; Published 31 March 2014

Academic Editor: Anil K. Agarwal

Copyright © 2014 Waldo H. Belloso et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Phair and F. Palella, “Renal disease in HIV-infected individuals,” Current Opinion in HIV and AIDS, vol. 6, no. 4, pp. 285–289, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. M. M. Estrella, D. M. Fine, and M. G. Atta, “Recent developments in HIV-related kidney disease,” HIV Therapy, vol. 4, no. 5, pp. 589–603, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Mocroft, O. Kirk, P. Reiss et al., “Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients,” AIDS, vol. 24, no. 11, pp. 1667–1678, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Mathew and S. J. Knaus, “Acquired Fanconi's syndrome associated with tenofovir therapy,” Journal of General Internal Medicine, vol. 21, no. 11, pp. C3–C5, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Fernandez-Fernandez, A. Montoya-Ferrer, A. B. Sanz et al., “Tenofovir nephrotoxicity: 2011 update,” AIDS Research and Treatment, vol. 2011, Article ID 354908, 11 pages, 2011. View at Publisher · View at Google Scholar
  6. S. Rodriguez-Novoa, E. Alvarez, P. Labarga, and V. Soriano, “Renal toxicity associated with tenofovir use,” Expert Opinion on Drug Safety, vol. 9, no. 4, pp. 545–559, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. R. D. Cooper, N. Wiebe, N. Smith, P. Keiser, S. Naicker, and M. Tonelli, “Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients,” Clinical Infectious Diseases, vol. 51, pp. 496–505, 2010. View at Google Scholar
  8. A. S. Go, G. M. Chertow, D. Fan, C. E. McCulloch, and C.-Y. Hsu, “Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization,” The New England Journal of Medicine, vol. 351, no. 13, pp. 1296–1370, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. A. I. Choi, Y. Li, S. G. Deeks, C. Grunfeld, P. A. Volberding, and M. G. Shlipak, “Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons,” Circulation, vol. 121, no. 5, pp. 651–658, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Dazo, P. Fahey, R. L. Puls et al., “Small and significant and non-progressive decline in glomerular filtration rate is observed in therapy-naive HIV-positive subjects commencing ritonavir-boosted atazanavir compared to either efavirenz or zidovudine/abacavir, all with tenofovir/emtricitabine after 48 weeks, a randomized controlled study,” in Proceedings of the 18th Conference on Retroviruses and Opportunistic infections (CROI '11), Boston, Mass, USA, March 2011.
  11. C. M. Wyatt, D. R. Hoover, Q. Shi et al., “Microalbuminuria is associated with all-cause and AIDS mortality in women with HIV infection,” Journal of Acquired Immune Deficiency Syndromes, vol. 55, no. 1, pp. 73–77, 2010. View at Google Scholar · View at Scopus
  12. L. I. Gardner, S. D. Holmberg, J. M. Williamson et al., “Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women,” Journal of Acquired Immune Deficiency Syndromes, vol. 32, no. 2, pp. 203–209, 2003. View at Google Scholar · View at Scopus
  13. A. Choi, R. Scherzer, P. Bacchetti et al., “Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons,” American Journal of Kidney Diseases, vol. 56, no. 5, pp. 872–882, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. S. K. Gupta, M. Smurzynski, N. Franceschini, R. J. Bosch, L. A. Szczech, and R. C. Kalayjian, “The effects of HIV type-1 viral suppression and non-viral factors on quantitative proteinuria in the highly active antiretroviral therapy era,” Antiviral Therapy, vol. 14, no. 4, pp. 543–549, 2009. View at Google Scholar · View at Scopus
  15. R. C. Kalayjian, “Renal issues in HIV infection,” Current HIV/AIDS Reports, vol. 8, no. 3, pp. 164–171, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. R. C. Kalayjian, “Kidney disease in HIV-infected persons,” Current Infectious Disease Reports, vol. 14, no. 1, pp. 83–90, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Samarawickrama, K. Nambiar, Y. Gilleece, M. Fisher, and S. Host, “Value of urine protein/creatinine and albumin/creatinine ratios in assessing renal disease in HIV infection,” in Proceedings of the 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, Calif, USA, Abstract 737, 2010.
  18. H. Vashistha, M. Husain, D. Kumar, and P. C. Singhal, “Tubular cell HIV-1 gp120 expression induces caspase 8 activation and apoptosis,” Renal Failure, vol. 31, no. 4, pp. 303–312, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. L. A. Szczech, “Renal dysfunction and tenofovir toxicity in HIV-infected patients,” Topics in HIV Medicine, vol. 16, no. 4, pp. 122–126, 2008. View at Google Scholar · View at Scopus
  20. S. M. E. Vrouenraets, C. A. Fux, F. W. N. M. Wit et al., “Persistent decline in estimated but not measured glomerular filtration rate on tenofovir may reflect tubular rather than glomerular toxicity,” AIDS, vol. 25, no. 17, pp. 2149–2155, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. A. M. Hall, S. G. Edwards, M. Lapsley et al., “Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis,” American Journal of Kidney Diseases, vol. 54, no. 6, pp. 1034–1042, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Labarga, P. Barreiro, L. Martin-Carbonero et al., “Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir,” AIDS, vol. 23, no. 6, pp. 689–696, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. J. F. Macías-Nuñez, C. García Iglesias, A. Bondía Román et al., “Renal handling of sodium in old people: a functional study,” Age and Ageing, vol. 7, no. 3, pp. 178–181, 1978. View at Google Scholar · View at Scopus
  24. C. G. Musso, I. Fainstein, R. Kaplan, and J. F. Macías-Nuñez, “Funcion tubular renal en el muy anciano,” Revista Española de Geriatría y Gerontología -, vol. 39, no. 5, pp. 314–319, 2004. View at Google Scholar
  25. C. G. Musso and J. F. Macías-Núñez, “Dysfunction of the thick loop of Henle and senescence: from molecular biology to clinical geriatrics,” International Urology and Nephrology, vol. 43, no. 1, pp. 249–252, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Maggi, V. Montinaro, C. Bellacosa et al., “Early markers of tubular dysfunction in antiretroviral-experienced HIV-infected patients treated with tenofovir versus abacavir,” AIDS Patient Care and STDs, vol. 26, no. 1, pp. 5–11, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Chaimovitz, J. Levi, O. S. Better, L. Oslander, and A. Benderli, “Studies on the site of renal salt loss in a patient with Bartter's syndrome,” Pediatric Research, vol. 7, no. 2, pp. 89–94, 1973. View at Google Scholar · View at Scopus
  28. M. Menon, A. Garcha, and A. Khanna, “The management of hyponatremia in HIV disease,” Journal of Nephrology, vol. 26, no. 01, pp. 61–72, 2013. View at Google Scholar
  29. S. K. Gupta, J. A. Eustace, J. A. Winston et al., “Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America,” Clinical Infectious Diseases, vol. 40, no. 11, pp. 1559–1585, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Lacy, L. Armstrong, M. Goldman, and L. Lance, Drug Information Handbook, Lexi-Comp, 2004.
  31. K. E. Vitting, M. H. Gardenswartz, P. M. Zabetakis et al., “Frequency of hyponatremia and nonosmolar vasopressin release in the acquired immunodeficiency syndrome,” Journal of the American Medical Association, vol. 263, no. 7, pp. 973–978, 1990. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Decaux, F. Vandergheynst, Y. Bouko, J. Parma, G. Vassart, and C. Vilain, “Nephrogenic syndrome of inappropriate antidiuresis in adults: high phenotypic variability in men and women from a large pedigree,” Journal of the American Society of Nephrology, vol. 18, no. 2, pp. 606–612, 2007. View at Publisher · View at Google Scholar · View at Scopus